Yacella® – A lower cost,1–3 bioequivalent alternative to Yasmin®4,5
- Yacella® is a monophasic combined oral contraceptive (COC), pill which contains 0.03 mg ethinylestradiol and 3 mg drospirenone3
- Yacella® contains the same active ingredients and has demonstrated bioequivalence to Yasmin®, therefore, following appropriate patient assessment and review, it may be prescribed in place of Yasmin®3–6
- Each pack of Yacella® contains 3 x blister strips of 21 tablets for 3 cycles of contraceptive cover7
References
- UK drug tariff (Accessed April 2024)
- NHS dm+d. Actual Medicinal Product (AMP) Yasmin tablets (Bayer PLC). Available at: https://dmd-browser.nhsbsa.nhs.uk/amp/view/8433 (accessed January 2024);
- NHS dm+d. Actual Medicinal Product (AMP) Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd). Available at: https://dmd-browser.nhsbsa.nhs.uk/amp/view/118813 (accessed January 2024);
- MHRA. UK PAR Yacella 0.03 mg/3 mg tablets. December 2015. Available at: https://mhraproductsproduction.blob.core.windows.net/docs/da60a925891cddb6949eeca3625262f534a3a163 (accessed January 2024);
- Bayer PLC. Yasmin PIL. Available at: https://www.medicines.org.uk/emc/files/pil.1607.pdf (accessed January 2024);
- Bayer PLC. Yasmin film-coated tablets 0.03mg/3mg. Summary of Product Characteristics. Available at: https://www.medicines.org.uk/emc/product/1607/smpc (accessed January 2024);
- NHS dm+d. Actual Medicinal Product Pack (AMPP) Yacella 0.03mg/3mg tablets (Morningside Healthcare Ltd) 63 tablet 3 x 21 tablets. Available at: https://dmd-browser.nhsbsa.nhs.uk/ampp/view/13667 (accessed January 2024).
Yasmin® chosen as a comparator as it is the license reference product for Yacella®.4,5